Serum aspartate aminotransferase is an adverse prognostic indicator for patients with resectable pancreatic ductal adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2023 at "Laboratory medicine"
DOI: 10.1093/labmed/lmad014
Abstract: OBJECTIVE In this study, the association between preoperative levels of serum liver enzymes and overall survival (OS) was evaluated in patients with resectable pancreatic cancer. METHODS Preoperative serum levels of alanine aminotransferase (ALT), aspartate aminotransferases… read more here.
Keywords: resectable pancreatic; serum; ductal adenocarcinoma; patients resectable ... See more keywords
Correlation of bile acids and aspartate-aminotransferase with outcomes in cholestasis of pregnancy.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of neonatal-perinatal medicine"
DOI: 10.3233/npm-190276
Abstract: OBJECTIVE To identify laboratory data that correlates with poor perinatal outcomes. METHODS A retrospective chart review of women with intrahepatic cholestasis of pregnancy (ICP), admitted for delivery between January 1, 2013 and December 31, 2017,… read more here.
Keywords: ast levels; cholestasis pregnancy; correlation; equal greater ... See more keywords